These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 30593710)

  • 1. Sex-related differences of clinical features in hidradenitis suppurativa: analysis of an Italian-based cohort.
    Bianchi L; Caposiena Caro RD; Ganzetti G; Molinelli E; Dini V; Oranges T; Romanelli M; Fabbrocini G; Monfrecola G; Napolitano M; Egan CG; Musumeci ML; Lacarrubba F; Micali G; Passoni E; Calzavara-Pinton PG; Venturini M; Zanca A; Offidani AM
    Clin Exp Dermatol; 2019 Jul; 44(5):e177-e180. PubMed ID: 30593710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hidradenitis Suppurativa in a Large Cohort of Italian Patients: Evaluation of the Burden of Disease.
    Fabbrocini G; Ruina G; Giovanardi G; Dini V; Raone B; Venturini M; Caposiena Caro RD; Veraldi S; Cannavò SP; Merlo G; Bertoldi AM; Fiorentini F; Molinelli E; Atzori L; Bongiorno MR; Lo Re M; Skroza N; Lasagni C; Franchi C; Ardigò M; Di Costanzo L; Stingeni L; Amerio P; Sanna F; Pescitelli L; Broganelli P; De Cupis C; Gualberti G; Saragaglia V; Argenziano G
    Dermatology; 2022; 238(3):487-497. PubMed ID: 34474409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of Characteristics and Trends in Treatment Response of Hidradenitis Suppurativa Patients: A Southern US Cohort Study.
    Peterson GC; Preston A; Frieder J; Wang X; Paek SY
    Dermatology; 2020; 236(5):413-420. PubMed ID: 31935718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Questionnaire-based epidemiological study of hidradenitis suppurativa in Japan revealing characteristics different from those in Western countries.
    Hayama K; Fujita H; Hashimoto T; Terui T;
    J Dermatol; 2020 Jul; 47(7):743-748. PubMed ID: 32441411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of inflammatory serum markers with disease severity in patients with hidradenitis suppurativa (HS).
    Hessam S; Sand M; Gambichler T; Bechara FG
    J Am Acad Dermatol; 2015 Dec; 73(6):998-1005. PubMed ID: 26410359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Could Residents Adequately Assess the Severity of Hidradenitis Suppurativa? Interrater and Intrarater Reliability Assessment of Major Scoring Systems.
    Włodarek K; Stefaniak A; Matusiak Ł; Szepietowski JC
    Dermatology; 2020; 236(1):8-14. PubMed ID: 31487719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of comorbid conditions burdening hidradenitis suppurativa: a multicentric observational study.
    Chiricozzi A; Giovanardi G; Caposiena Caro DR; Iannone M; De Simone C; Cannizzaro MV; Oranges T; Fossati B; Di Matteo E; Dini V; Bianchi L; Peris K
    G Ital Dermatol Venereol; 2020 Jun; 155(3):335-340. PubMed ID: 30295448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel Severity Assessment Scoring System for Hidradenitis Suppurativa.
    Hessam S; Scholl L; Sand M; Schmitz L; Reitenbach S; Bechara FG
    JAMA Dermatol; 2018 Mar; 154(3):330-335. PubMed ID: 29417136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baseline Characteristics of a National French E-Cohort of Hidradenitis Suppurativa in ComPaRe and Comparison with Other Large Hidradenitis Suppurativa Cohorts.
    Condamina M; Penso L; Tran VT; Hotz C; Guillem P; Villani AP; Perrot P; Bru MF; Jacquet E; Nassif A; Bachelez H; Wolkenstein P; Beylot-Barry M; Richard MA; Ravaud P; Viguier M; Sbidian E
    Dermatology; 2021; 237(5):748-758. PubMed ID: 33503635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of the refined Hurley classification for hidradenitis suppurativa with patient-reported quality of life and objective disease severity assessment.
    Rondags A; van Straalen KR; van Hasselt JR; Janse IC; Ardon CB; Vossen ARJV; Prens EP; van der Zee HH; Horváth B
    Br J Dermatol; 2019 May; 180(5):1214-1220. PubMed ID: 30512186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrasonography in the pathway to an optimal standard of care of hidradenitis suppurativa: the Italian Ultrasound Working Group experience.
    Lacarrubba F; Dini V; Napolitano M; Venturini M; Caposiena Caro DR; Molinelli E; Passoni E; Monfrecola G;
    J Eur Acad Dermatol Venereol; 2019 Oct; 33 Suppl 6():10-14. PubMed ID: 31535763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased risk of permanent stoma in Crohn's disease associated with hidradenitis suppurativa: a case-control study.
    Dumont LM; Landman C; Sokol H; Beaugerie L; Cosnes J; Seksik P; Guégan S;
    Aliment Pharmacol Ther; 2020 Jul; 52(2):303-310. PubMed ID: 32525586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hidradenitis suppurativa: a retrospective study of 846 Dutch patients to identify factors associated with disease severity.
    Schrader AM; Deckers IE; van der Zee HH; Boer J; Prens EP
    J Am Acad Dermatol; 2014 Sep; 71(3):460-7. PubMed ID: 24880664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Belgian Patients of the European Registry for Hidradenitis Suppurativa (ERHS-Be): Data, Scores, and Phenotypes since 2015.
    Heudens S; Sarkis AS; Daoud M; Daxhelet M; Benhadou F; Suppa M; Nobile L; Karama J; Njimi H; White JM; Del Marmol V
    Dermatology; 2024; 240(4):553-564. PubMed ID: 38621365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demographic and clinical features of hidradenitis suppurativa in Korea.
    Yang JH; Moon J; Kye YC; Kim KJ; Kim MN; Ro YS; Park MY; Ahn HH; Lee MW; Lee WJ; Lee JH; Lee JB; Jang MS; Choi YS; Choi YW; Suh DH;
    J Dermatol; 2018 Dec; 45(12):1389-1395. PubMed ID: 30294846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inter-rater agreement and reliability of outcome measurement instruments and staging systems used in hidradenitis suppurativa.
    Thorlacius L; Garg A; Riis PT; Nielsen SM; Bettoli V; Ingram JR; Del Marmol V; Matusiak L; Pascual JC; Revuz J; Sartorius K; Tzellos T; van der Zee HH; Zouboulis CC; Saunte DM; Gottlieb AB; Christensen R; Jemec GBE
    Br J Dermatol; 2019 Sep; 181(3):483-491. PubMed ID: 30724351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical, biochemical, and ultrasonographic characteristics of patients with hidradenitis suppurativa in Northern Peninsular Malaysia: a multicenter study.
    Loo CH; Tan WC; Tang JJ; Khor YH; Manikam MT; Low DE; Chan KH; Chan KH; Teoh YM; Sohot NQA; Tang MM; Chan LC
    Int J Dermatol; 2018 Dec; 57(12):1454-1463. PubMed ID: 30182482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors affecting quality of life in patients with hidradenitis suppurativa.
    Jørgensen AR; Holm JG; Ghazanfar MN; Yao Y; Ring HC; Thomsen SF
    Arch Dermatol Res; 2020 Aug; 312(6):427-436. PubMed ID: 31848682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AISI: A New Disease Severity Assessment Tool for Hidradenitis Suppurativa.
    Chiricozzi A; Faleri S; Franceschini C; Caro RD; Chimenti S; Bianchi L
    Wounds; 2015 Oct; 27(10):258-64. PubMed ID: 26479209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a novel dynamic scoring system to assess HS severity.
    Zouboulis CC; Tzellos T; Kyrgidis A; Jemec GBE; Bechara FG; Giamarellos-Bourboulis EJ; Ingram JR; Kanni T; Karagiannidis I; Martorell A; Matusiak Ł; Pinter A; Prens EP; Presser D; Schneider-Burrus S; von Stebut E; Szepietowski JC; van der Zee HH; Wilden SM; Sabat R;
    Br J Dermatol; 2017 Nov; 177(5):1401-1409. PubMed ID: 28636793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.